Sorbinil treatment prevented FGF and platelet-derived growth factor (PDGF)-induced growth of Caco-2 colon cancer cells and attenuated COX-2, PGE2, NF-κB activation, and PKC as well as phosphorylation of PKC-beta2. This evidence concerns the gene NFKB1 and malignant colon neoplasm.